Paul-Emmanuel Vanderriele

Dr. Paul-Emmanuel Vanderriele

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 August 2022 in Antioxidants
Verified
Journal Article
Open access
PDF file
BKBasile Keshavjee
Basile Keshavjee
VLValentine Lambelet
Valentine Lambelet
HCHanna Coppola
Hanna Coppola
DVDavid Viertl
David Viertl
John PriorJohn Prior
John Prior
CYCatherine YZYDORCZYK
Catherine YZYDORCZYK
Metabolic syndrome (MetS) refers to cardiometabolic risk factors, such as visceral obesity, dyslipidemia, hyperglycemia/insulin resistance, arterial hypertension and non-alcoholic fatty liver disease (NAFLD). Individuals born after intrauterine growth restriction (IUGR) are particularly at risk of developing metabolic/hepatic disorders later in life. Oxidative stress and cellular senescence have been associated with MetS and are observed in infants born following IUGR. However, whether these mechanisms could be particularly associated with the development of NAFLD in these individuals is still unknown. IUGR was induced in rats by a maternal low-protein diet during gestation versus. a control (CTRL) diet. In six-month-old offspring, we observed an increased visceral fat mass, glucose intolerance, and hepatic alterations (increased transaminase levels, triglyceride and neutral lipid deposit) in male rats with induced IUGR compared with the CTRL males; no differences were found in females. In IUGR male livers, we identified some markers of stress-induced premature senescence (SIPS) (lipofuscin deposit, increased protein expression of p21WAF, p16INK4a and Acp53, but decreased pRb/Rb ratio, foxo-1 and sirtuin-1 protein and mRNA expression) associated with oxidative stress (higher superoxide anion levels, DNA damages, decreased Cu/Zn SOD, increased catalase protein expression, increased nfe2 and decreased keap1 mRNA expression). Impaired lipogenesis pathways (decreased pAMPK/AMPK ratio, increased pAKT/AKT ratio, SREBP1 and PPARγ protein expression) were also observed in IUGR male livers. At birth, no differences were observed in liver histology, markers of SIPS and oxidative stress between CTRL and IUGR males. These data demonstrate that the livers of IUGR males at adulthood display SIPS and impaired liver structure and function related to oxidative stress and allow the identification of specific therapeutic strategies to limit or prevent adverse consequences of IUGR, particularly metabolic and hepatic disorders.

22 June 2022 in Pflügers Archiv - European Journal of Physiology
Verified
Journal Article
Open access
PDF file
SVSofia N. Verouti
Sofia N. Verouti
EHEdith Hummler
Edith Hummler
PVPaul-Emmanuel Vanderriele
Paul-Emmanuel Vanderriele
Hypertension is one of the leading causes of premature death in humans and exhibits a complex aetiology including environmental and genetic factors. Mutations within the glucocorticoid receptor (GR) can cause glucocorticoid resistance, which is characterized by several clinical features like hypercortisolism, hypokalaemia, adrenal hyperplasia and hypertension. Altered glucocorticoid receptor signalling further affects sodium and potassium homeostasis as well as blood pressure regulation and cell proliferation and differentiation that influence organ development and function. In salt-sensitive hypertension, excessive renal salt transport and sympathetic nervous system stimulation may occur simultaneously, and, thus, both the mineralocorticoid receptor (MR) and the GR-signalling may be implicated or even act interdependently. This review focuses on identified GR mutations in human primary generalized glucocorticoid resistance (PGGR) patients and their related clinical phenotype with specific emphasis on adrenal gland hyperplasia and hypertension. We compare these findings to mouse and rat mutants harbouring genetically engineered mutations to further dissect the cause and/or the consequence of clinical features which are common or different.

Verified
Journal Article
Open access
PDF file
PVPaul-Emmanuel Vanderriele
Paul-Emmanuel Vanderriele
QWQing Wang
Qing Wang
AMAnne-Marie Mérillat
Anne-Marie Mérillat
FIFrédérique Ino
Frédérique Ino
GAGilles Aeschlimann
Gilles Aeschlimann
SVSofia N. Verouti
Sofia N. Verouti
Mutations within the glucocorticoid receptor (GR) gene locus lead to glucocorticoid resistance which is characterized by several clinical symptoms such as adrenal gland hyperplasia and salt-sensitive hypertension, although the underlying mechanisms are still unknown. We studied GR haploinsufficient (GR+/−) Sprague Dawley rats which, on a standard diet, showed significantly increased plasma aldosterone and corticosterone levels and an adrenocortex hyperplasia accompanied by a normal systolic blood pressure. Following a high salt diet, these rats developed salt-sensitive hypertension and maintained elevated enzyme-soluble epoxide hydrolase (sEH) in adrenal glands, while sEH was significantly decreased in wild-type rats. Furthermore, GR+/− rats showed dysregulation of the equilibrated linoleic and arachidonic acid pathways, with a significant increase of less active metabolites such as 8,9-DiHETrE. In Sprague Dawley rats, GR haploinsufficiency induced steroid disturbances, which provoked hypertension only in combination with high salt intake, which was accompanied by disturbances in sEH and fatty acid metabolism. Our results suggest that sEH inhibition could be a potential target to treat hypertension in patients with GR haploinsufficiency.

10 September 2024 in Pflügers Archiv - European Journal of Physiology
Verified
Journal Article
Open access
PDF file
SVSofia N. Verouti
Sofia N. Verouti
GAG. Aeschlimann
G. Aeschlimann
QWQing Wang
Qing Wang
DOD. Ancin Del Olmo
D. Ancin Del Olmo
APAnne-Christine Peyter
Anne-Christine Peyter
PVPaul-Emmanuel Vanderriele
Paul-Emmanuel Vanderriele
In humans, glucocorticoid resistance is attributed to mutations in the glucocorticoid receptor (GR). Most of these mutations result in decreased ligand binding, transactivation, and/or translocation, albeit with normal protein abundances. However, there is no clear genotype‒phenotype relationship between the severity or age at disease presentation and the degree of functional loss of the receptor. Previously, we documented that a GR+/− rat line developed clinical features of glucocorticoid resistance, namely, hypercortisolemia, adrenal hyperplasia, and salt-sensitive hypertension. In this study, we analyzed the GR+/em4 rat model heterozygously mutant for the deletion of exon 3, which encompasses the second zinc finger, including the domains of DNA binding, dimerization, and nuclear localization signals. On a standard diet, mutant rats exhibited a trend toward increased corticosterone levels and a normal systolic blood pressure and heart rate but presented with adrenal hyperplasia. They exhibited increased adrenal soluble epoxide hydroxylase (sEH), favoring an increase in less active polyunsaturated fatty acids. Indeed, a significant increase in nonactive omega-3 and omega-6 polyunsaturated fatty acids, such as 5(6)-DiHETrE or 9(10)-DiHOME, was observed with advanced age (10 versus 5 weeks old) and following a switch to a high-salt diet accompanied by salt-sensitive hypertension. In thoracic aortas, a reduced soluble epoxide hydrolase (sEH) protein abundance resulted in altered vascular reactivity upon a standard diet, which was blunted upon a high-salt diet. In conclusion, mutations in the GR affecting the ligand-binding domain as well as the dimerization domain resulted in deregulated GR signaling, favoring salt-sensitive hypertension in the absence of obvious mineralocorticoid excess.

1 November 2024 in Innovations & Thérapeutiques en Oncologie
Verified
Journal Article
Closed access
PDF file
PVPaul-Emmanuel Vanderriele
Paul-Emmanuel Vanderriele

14 May 2021 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
PVPaul-Emmanuel Vanderriele
Paul-Emmanuel Vanderriele
QWQing Wang
Qing Wang
VLVerónica Ponce de León
Verónica Ponce de León
DKDenise Kratschmar
Denise Kratschmar
AOAlex Odermatt
Alex Odermatt
SVSofia N. Verouti
Sofia N. Verouti
In human, mutations of the glucocorticoid receptor ( NR3C1, GR) that cause a glucocorticoid resistance cause in about 40% hypertension. However, the underlying causes are still largely unknown. To determine the impact of GR mutations on adrenal gland function, steroid expression and development of hypertension, we generated rats carrying a deletion within the second zinc finger of the GR, named GR +/em2 (Ponce de León. V et al ; Plos One, 2014) resulting in GR haploinsufficiency. Heterozygous mutant GR +/em2 rats showed a monolateral adrenal hyperplasia with hyperkalemia, a disturbance in the steroid profile with an increase of plasma aldosterone, corticosterone, 11‐deoxycorticosterone despite a normal activity of the 11‐β‐hydroxysteroid‐dehydrogenase II suggesting an absence of mineralocorticoid protection. Under high salt diet (about 4,3% of salt), GR +/em2 mutant rats developed a significantly increased salt‐sensitive hypertension accompanied by an increase of adrenal and kidney weight. Using RNAseq analyses, we identified a significant increased expression of the soluble epoxide hydrolase gene ( EPHX2 ) in GR +/em2 adrenal tissue on normal diet. This increase has been confirmed at the mRNA transcript expression level. Upon high salt diet, adrenal sEH protein expression was significantly decreased in wildtype, but not in the salt‐sensitive GR +/em2 rats. This suggests a higher level of the diol‐eipoxyeicosanoid acids in GR +/em2 plasma and an impairment of the protective mechanism leading to the development of hypertension. This new rat model is therefore useful to understand the underlying mechanism of salt‐sensitive hypertension in glucocorticoid resistance syndrome and may thus provide a new therapeutic approach for the treatment of NR3C1 ‐induced hypertension.